119th Congress (2025-2026)

HR 8260

Cardiovascular Disease Early Detection and Prevention Act of 2026

Introduced

Jurisdiction

US Congress

Session

119th Congress (2025-2026)

Official source

Chamber

House

Session

119th Congress (2025-2026)

Jurisdiction

US Congress

Bill overview

The Cardiovascular Disease Early Detection and Prevention Act of 2026 aims to improve cardiovascular health by requiring coverage of specific blood tests – lipoprotein(a) and apolipoprotein B levels – without cost-sharing for individuals at higher risk. This includes those with a family history of heart disease, previous heart attacks or strokes, diabetes, or obesity. The bill expands coverage to Medicare, Medicaid, and private health insurance plans, focusing on early detection and risk management.

Key provisions

Requires coverage of lipoprotein(a) and apolipoprotein B testing without cost-sharing.
Expands coverage to individuals with family history of cardiovascular disease, heart attack, stroke, diabetes, or obesity.
Includes coverage for Medicare, Medicaid, and private health insurance plans.
Amends the Public Health Service Act to specifically include lipoprotein(a) and apolipoprotein B testing in coverage requirements.
Modifies Medicare coverage to include lipoprotein(a) and apolipoprotein B testing for high-risk individuals.
Updates Medicaid coverage to include lipoprotein(a) and apolipoprotein B testing for high-risk individuals.
Changes the application of cost-sharing rules to exclude these specific tests.
Establishes a timeline for the effective date of the changes, 180 days after enactment.

Who is affected

Individuals at risk for cardiovascular disease
Medicare beneficiaries
Medicaid recipients

Positions across the country

No public positions recorded for this legislation.

Arguments in favor

Reasons to support this legislation.

No arguments in favor have been submitted.

Submit yours

Arguments opposed

Reasons to oppose this legislation.

No arguments opposed have been submitted.

Submit yours

Legislative history

2026-04-14House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2026-04-14House

2026-04-14

Introduced in House

2026-04-14

Introduced in House

Read the latest version inline or switch to a previous version.

Apr 14, 2026XMLView source

119th CONGRESS — 2d Session

H. R. 8260

IN THE HOUSE OF REPRESENTATIVES

A BILL

To amend title XXVII of the Public Health Service Act and titles XVIII and XIX of the Social Security Act to require coverage of certain cardiovascular tests without cost sharing under group health plans, group and individual health insurance coverage, and the Medicare and Medicaid programs.

1.Short title

This Act may be cited as the

Cardiovascular Disease Early Detection and Prevention Act of 2026

2.Findings

Congress finds the following:

(1)Cardiovascular disease is the leading cause of death in the United States.

(2)Routine cholesterol panels often fail to detect elevated Lipoprotein(a) (Lp(a)) and Apolipoprotein B (ApoB) levels.

(3)Approximately 1 in 5 Americans have elevated Lp(a) levels.

(4)Elevated ApoB levels predict cardiovascular risk better than LDL cholesterol alone.

(5)Nearly 50 percent of heart attack survivors die within five years without effective risk management.

3.Requiring coverage of certain cardiovascular tests without cost sharing under group health plans, group and individual health insurance coverage, and the Medicare and Medicaid programs

(a)Public Health Service ActSection 2713(a) of the Public Health Service Act (42 U.S.C. 300gg–13(a)) is amended—

(1)

in paragraph (2), by striking and at the end;

(2)

in paragraph (3), by striking the period and inserting a semicolon;

(3)

by redesignating paragraphs (4) and (5) as paragraphs (5) and (6), respectively; and

(4)

by inserting after paragraph (3) the following new paragraph:

(4)with respect to individuals with a family history of premature cardiovascular disease, a personal history of myocardial infarction, stroke, or elevated LDL cholesterol, a diagnosis of diabetes mellitus or obesity, or other recognized cardiovascular risk factors, testing for lipoprotein(a) and apolipoprotein B levels; and

(b)Medicare

(1)In generalSection 1861(xx)(1) of the Social Security Act (42 U.S.C. 1395x(xx)(1)) is amended—

(A)

by redesignating subparagraph (B) as subparagraph (C);

(B)

by inserting after subparagraph (A) the following new subparagraph:

(B)In the case of an individual with a family history of premature cardiovascular disease, a personal history of myocardial infarction, stroke, or elevated LDL cholesterol, a diagnosis of diabetes mellitus or obesity, or other recognized cardiovascular risk factors, lipoprotein(a) and apolipoprotein B levels.

; and

(C)

in the flush matter at the end, by striking subparagraph (B) and inserting subparagraph (C).

(2)No application of cost sharing

Section 1833 of the Social Security Act (42 U.S.C. 1395l) is amended—

(A)

in subsection (a)(1)(Y), by inserting (other than tests for levels described in section 1861(ww)(1)(B) furnished to an individual described in such section) after described in subparagraph (A); and

(B)

in subsection (b)(1), by striking for the individual. inserting for the individual or that are tests for levels described in section 1861(ww)(1)(B) furnished to an individual described in such section.

(c)Medicaid

(1)In generalSection 1905(a) of the Social Security Act (42 U.S.C. 1396d(a)) is amended—

(A)

in paragraph (31), by striking and at the end;

(B)

by redesignating paragraph (32) as paragraph (33); and

(C)

by inserting after paragraph (31) the following new paragraph:

(32)testing for lipoprotein(a) and apolipoprotein B levels furnished to an individual with a family history of premature cardiovascular disease, a personal history of myocardial infarction, stroke, or elevated LDL cholesterol, a diagnosis of diabetes mellitus or obesity, or other recognized cardiovascular risk factors; and

(2)No cost sharing

(A)In generalSubsections (a)(2) and (b)(2) of section 1916 of the Social Security Act (42 U.S.C. 1396o) are each amended—

(i)

in subparagraph (I), by striking or at the end;

(ii)

in subparagraph (J), by striking ; and and inserting , or; and

(iii)

by adding at the end the following new subparagraph:

(K)testing for lipoprotein(a) and apolipoprotein B levels furnished to an individual described in section 1905(a)(32); and

(B)Application to alternative cost sharingSection 1916A(b)(3)(B) of the Social Security Act (42 U.S.C. 1396o–1(b)(3)(B)) is amended by adding at the end the following new clause:

(xv)Testing for lipoprotein(a) and apolipoprotein B levels furnished to an individual described in section 1905(a)(32).

(3)Mandatory coverage

Section 1902(a)(10)(A) of the Social Security Act (42 U.S.C. 1396a(a)(10)(A)) is amended by striking and (30) and inserting (30), and (32).

(4)Benchmark coverage and benchmark-equivalent coverage

Section 1937(b) of the Social Security Act (42 U.S.C. 1396u–7(b)) is amended by adding at the end the following new paragraph:

(9)Coverage of certain lipid level testingNotwithstanding the previous provisions of this section, a State may not provide for medical assistance through enrollment of an individual with benchmark coverage or benchmark-equivalent coverage under this section unless such coverage provides, with respect to an individual described in section 1905(a)(32), testing for lipoprotein(a) and apolipoprotein B levels.

(d)Effective date

The amendments made by—

(1)

subsection (a) shall apply with respect to plan years beginning on or after the date that is 180 days after the date of the enactment of this Act; and

(2)

subsections (b) and (c) shall apply with respect to items and services and medical assistance, respectively, furnished on or after such date.

HR 8260

Bill overview

Key provisions

Who is affected

Sponsors

Primary sponsor

Positions across the country

Arguments in favor

Arguments opposed

Bill text

Notable changes

Positions across the country